Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

Geriatric Assessment and Management for Older Adults Undergoing Radiation Therapy for Head and Neck Cancer and Their Family Caregivers

NCT ID: NCT07225855Sponsor: City of Hope Medical CenterLast updated: 2026-05-11

Summary

This clinical trial compares the effect of geriatric assessment (GA)-based management of supportive care to usual care in treating older patients undergoing chemotherapy and radiation therapy for head and neck cancer and their family caregivers (FCG). At least one quarter of head and neck cancers patients are diagnosed at age 70 or older. Treatment for head and neck cancers usually include surgery, chemotherapy, and radiation. Older adults are often at higher risk for functional problems, and may experience more side effects. In addition, there may be a lack of support mechanisms in place to address the needs of these older patients. Cancer not only affects the patients but the entire family, especially the family member who is the caregiver. Currently, all patients over 65 receive the same standard of care based on national guidelines, which include supportive care referrals. However, data suggests, that many patients may need more frequent and structured support. The Practical Geriatric Assessment (PGA) is a complete examination including evaluation of the physical and mental function as well as the emotional state of the older patient. PGA-based supportive care interventions may be safe, tolerable, and/or effective in managing treatment-related side effects and improving quality of life compared to usual care in older patients undergoing chemotherapy and radiation therapy for head and neck cancer and their FCG.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate the safety of the intervention by evaluation of treatment-related toxicities. SECONDARY OBJECTIVES: I. To assess the feasibility, retention, and acceptability of the intervention. II. To assess the rate of any grade non-hematologic treatment-related toxicities. III. To assess patient/FCG self-reported outcomes. IV. To assess the symptom-related outcomes by evaluation of unplanned readmissions and emergency room (ER)/urgent care visits. OUTLINE: Patients are randomized to 1 of 2 arms. Caregivers are randomized to the same arm as the corresponding patients. ARM A (GA-DRIVEN INTERVENTION): Patients undergo PGA at baseline, at 4 weeks and at 1 month after completing treatment. Assessment results shared with treating oncologists and patients receive referrals to supportive care services for the problems identified with the assessment throughout the study. Caregivers may receive referrals to resources and programs. ARM B (USUAL CARE): Patients attend regular clinical visits for treatment and follow up and receive usual care provided by their radiation oncology and medical oncology teams and referrals to supportive care services as needed throughout the study. After completion of study interventions, patients are followed up at 1 and 3 months.

Arms & interventions

  • OtherBest Practice

    Receive usual care

  • OtherElectronic Health Record Review

    Ancillary studies

  • BehavioralHealth Communication

    Shared with treating oncology

  • OtherInterview

    Ancillary studies

  • OtherOffice Visit

    Attend regular clinical visits

  • OtherPractical Geriatric Assessment

    Undergo PGA

  • OtherQuestionnaire Administration

    Ancillary studies

  • OtherReferral

    Receive referrals to resources and programs

  • OtherReferral

    Receive referrals to supportive care services

  • OtherSupportive Care

    Receive referrals to supportive care services

Outcome measures

Primary

  • Proportion of grade 2-5 non-hematologic treatment-related toxicities

    Will be assessed in patients using Common Terminology Criteria for Adverse Events (CTCAE) version (v) 5.0. Will be summarized using descriptive statistics. For continuous variables, descriptive statistics such as number, mean, standard deviation, standard error, median (range) etc. will be provided. For categorical variables, counts and percentages will be provided. Observed toxicities will be summarized by type, severity, and attribution. Rates will be estimated along with the 95% exact binomial confidence interval.

    Time frame: Up to 3 months after completion of treatment

Secondary

  • Percentage of eligible participants who enroll in the study

    Time frame: Up to 1 year

  • Retention rate

    Time frame: Up to 3 months after completion of study treatment

  • Acceptability of the intervention

    Time frame: Up to 3 months after completion of treatment

  • Proportion of any-grade non-hematologic treatment-related toxicities

    Time frame: Up to 3 months after completion of treatment

  • Patient/family caregiver self-reported outcomes

    Time frame: Up to 3 months after completion of treatment

  • Rate of unplanned readmissions

    Time frame: Up to 3 months after completion of treatment

  • Rate of emergency room/urgent care visits

    Time frame: Up to 3 months after completion of treatment

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: Yes
Inclusion Criteria: * PATIENT: Documented written informed consent of the participant * PATIENT: Diagnosis of non-metastatic head and neck cancer * PATIENT: Age: ≥ 60 years * PATIENT: Patient must be scheduled to undergo curative-intent, definitive radiation with or without concurrent chemotherapy or postoperative radiation with or without concurrent chemotherapy * PATIENT: Patients must have at least one geriatric assessment as assessed by the modified Geriatric 8 (G8) tool * PATIENT: Family caregivers (FCGs) are highly encouraged to participate but this is not required. Patients without FCGs will be eligible to participate in the study. FCGs will be randomized to the same arm as their corresponding patients * PATIENT: Ability to read and understand English * CAREGIVER: A family member or friend identified by the patient and defined as a person who knows the patient well and is involved in the patient's medical care * CAREGIVER: Ability to read and understand English * CAREGIVER: Age 18 years or older

Study locations (1)

City of Hope Medical Center

Duarte, California, 91010

Recruiting
Arya Amini · Contact
Arya Amini · Principal Investigator
Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers | Cancerify